Log in to search using one of your social media accounts:

Broader availability of opioid overdose drug is saving lives
America ’s opioid addiction epidemic was one of the biggest health stories of 2016, as reflected in the intense media coverage the topic received — and it is no wonder why. The number of deaths involving prescription opioid medications and heroin continues to rise, having quadrupled since 1999. Some 91 Americans die each day from an opioid overdose, according to the U.S. Centers for Disease Control and Prevention.One key strategy in the battle to curb opioid overdose deaths has been the use of the drug naloxone, which emergency medical personnel and first responders have used for years to treat people suffering...
Source: UCLA Newsroom: Health Sciences - February 9, 2017 Category: Universities & Medical Training Source Type: news

Flu vaccine effectiveness 'decent' at 42% this season in Canada, researchers say
A group of infectious disease experts estimates that this season's influenza vaccine has been more than 40 per cent effective in preventing the respiratory illness in Canadians who got the shot. (Source: CBC | Health)
Source: CBC | Health - February 9, 2017 Category: Consumer Health News Tags: News/Health Source Type: news

Flu vaccine effectiveness 'decent' at 42 per cent this season in Canada: researchers
A group of infectious disease experts estimates that this season's influenza vaccine has been more than 40 per cent effective in preventing the respiratory illness in Canadians who got the shot. (Source: CBC | Health)
Source: CBC | Health - February 9, 2017 Category: Consumer Health News Tags: News/Health Source Type: news

Acorda ’ s inhaled Parkinson ’ s drug meets primary endpoint in Phase III trial
Acorda Therapeutics (NSDQ:ACOR) said today that the phase III clinical trial evaluating its inhaled formulation of Parkinson’s drug levodopa met its primary endpoint. The drug was studied as a therapy for people with Parkinson’s disease experiencing “off” periods, or a re-emergence of symptoms. The randomized phase III trial enrolled 339 patients to evaluate the efficacy and safety of CVT-301 compared with a placebo in patients with Parkinson’s who experience motor fluctuations. Study participants self-administered the therapy up to 5 times per day for 12 weeks. Get the full story at our siste...
Source: Mass Device - February 9, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals Respiratory Wall Street Beat Acorda Therapeutics Source Type: news

Mould in the Home
Thu, 02/09/2017 - 14:35News blog (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 9, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Smoke-Free Public Housing Cuts Secondhand Fumes
Title: Smoke-Free Public Housing Cuts Secondhand FumesCategory: Health NewsCreated: 2/8/2017 12:00:00 AMLast Editorial Review: 2/9/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 9, 2017 Category: Respiratory Medicine Source Type: news

Toxic Metals Found in E-Cigarette Liquid
Title: Toxic Metals Found in E-Cigarette LiquidCategory: Health NewsCreated: 2/8/2017 12:00:00 AMLast Editorial Review: 2/9/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 9, 2017 Category: Respiratory Medicine Source Type: news

E-Cigs May Be 'Bridge' to Teens' Tobacco Use
Title: E-Cigs May Be 'Bridge' to Teens' Tobacco UseCategory: Health NewsCreated: 2/8/2017 12:00:00 AMLast Editorial Review: 2/9/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 9, 2017 Category: Respiratory Medicine Source Type: news

What Causes Asthma?
Title: What Causes Asthma?Category: Doctor's& Expert's views on SymptomsCreated: 1/16/2002 12:00:00 AMLast Editorial Review: 2/9/2017 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - February 9, 2017 Category: Respiratory Medicine Source Type: news

New $3.2 million NIH grant supports nation's first mobile post-ICU recovery program
(Indiana University) Two million of the five million Americans admitted to intensive care units annually have or develop acute respiratory failure. $3.2 million NIH grant funds development and evaluation of the novel mobile Critical Care Recovery Program by the Indiana University Center for Aging Research. Program builds upon innovative outpatient clinic that was nation's first collaborative care concept focusing on the extensive cognitive, physical and psychological recovery needs of intensive care unit survivors. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 9, 2017 Category: Global & Universal Source Type: news

Opioids and Alcohol a Dangerous Cocktail
Drinking while taking the painkillers can hamper breathing, especially among seniors, study finds (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - February 8, 2017 Category: Respiratory Medicine Authors: webmaster at doctorslounge.com Tags: Pharmacy, Pulmonology, Preventive Medicine, News, Source Type: news

Arms Pharmaceutical touts oral spray for upper respiratory tract infections
Arms Pharmaceutical touted data from a proof-of-concept clinical trial evaluating its oral spray formulation, Arms-I, for upper respiratory tract infections. The placebo-controlled trial demonstrated that the oral spray formulation is safe, well-tolerated and reduced influenza symptoms, according to the Cleveland-based pharmaceutical company. Get the full story at our sister site, Drug Delivery Business News. The post Arms Pharmaceutical touts oral spray for upper respiratory tract infections appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 8, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Respiratory Wall Street Beat Arms Pharmaceutical Source Type: news

Propeller and Novartis collaborate to develop add-on sensor for COPD treatments
Digital respiratory health management company Propeller Health is collaborating with Novartis to develop a custom add-on sensor for the Swiss pharmaceutical company ’s Breezhaler inhaler, which is used for Novartis’s portfolio of COPD treatments. The partnership will be focused in Europe. (Source: mobihealthnews)
Source: mobihealthnews - February 8, 2017 Category: Information Technology Source Type: news

Propeller Health, Novartis ink collaboration for connected inhaler
Propeller Health said today that it landed a collaborative agreement with Novartis (NYSE:NVS) to develop a custom add-on sensor for the Breezhaler inhaler. The partnership is focused on patients with chronic obstructive pulmonary disease in Europe. The Breezhaler is a capsule-based, dry powder inhaler and is a part of Novartis’ portfolio of COPD therapies. The custom sensors developed as a result of this collaboration will passively record and transmit compliance data, according to Propeller, which will better inform patients and physicians of adherence. Get the full story at our sister site, Drug Delivery ...
Source: Mass Device - February 8, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Drug-Device Combinations Research & Development Respiratory Wall Street Beat Novartis AG Propeller Health Source Type: news

Opioids and Alcohol a Dangerous Cocktail
WEDNESDAY, Feb. 8, 2017 -- Drinking alcohol while taking powerful opioid painkillers can trigger a potentially deadly respiratory problem, particularly in seniors, a new study warns. " Unfortunately, we're seeing more fatalities and people in... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 8, 2017 Category: Journals (General) Source Type: news

IDWeek
Date: Wednesday, February 8, 2017Year: 2017Location: San Diego, USAContent-type: current_conferences (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 8, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Shortest Research Paper Ever Written
Wed, 02/08/2017 - 12:12News blog (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 8, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Fungal Pathogen Genomics workshop
Aims to provide experimental biologists working on fungal organisms with hands-on experience in genomic-scale data analysisCourses& Workshops (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 8, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

BEI Resources
Link: BEI Resources websiteContent-type: links (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 8, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

NIH Grants: International Research in Infectious Diseases, including AIDS (R01)
Link: NIH websiteContent-type: links (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 8, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Distinguished Professorship in Medical Mycology
(Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 8, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Postdoctoral Position
(Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 8, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Emphysema Treatment
Title: Emphysema TreatmentCategory: Doctor's& Expert's views on SymptomsCreated: 11/3/2014 12:00:00 AMLast Editorial Review: 2/8/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 8, 2017 Category: Respiratory Medicine Source Type: news

Capnographic Monitoring of Feeding Tube Insertion Capnographic Monitoring of Feeding Tube Insertion
Is capnographic monitoring useful to prevent respiratory complications due to feeding tube mispositioning in critically ill patients?BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 8, 2017 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Paralyzed man's family fear ACA repeal, despite not being enrolled
Howard and Mary Ann Claytor's living room is a jumble of medical devices, looking more like an intensive care unit than a home. It is filled with breathing machines, respiratory monitors, a manual lift and feeding tubes, all aimed at keeping their paralyzed 29-year-old son, Cedric, alive. (Source: CNN.com - Health)
Source: CNN.com - Health - February 7, 2017 Category: Consumer Health News Source Type: news

E-Cigarettes May Be Less Toxic Than Tobacco, Study Suggests
Title: E-Cigarettes May Be Less Toxic Than Tobacco, Study SuggestsCategory: Health NewsCreated: 2/6/2017 12:00:00 AMLast Editorial Review: 2/7/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 7, 2017 Category: Respiratory Medicine Source Type: news

New at-home sleep apnea tests compete with for-profit labs
This figure shows the airway path and the obstruction caused by sleep apnea. [Image from Wikipedia]The big business in laboratory sleep apnea testing has a new competitor in the homes of obstructive sleep apnea sufferers. Portable sleep monitors could be used to test for obstructive sleep apnea at home when testing in a laboratory is not suitable. It is often referred to as the “unattended sleep study.” At-home sleep apnea tests usually check nasal and oral airflow and respiratory effort and use an oxymeter finger probe. Users tape a thin wire by the nose and mouth and place an elastic belt band across the ches...
Source: Mass Device - February 6, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Laboratory Instruments/Laboratory Supplies Sleep Monitoring/Sleep Apnea Source Type: news

Aspergillosis Hospitalisations Rise 50%
Mon, 02/06/2017 - 16:53News blog (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 6, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Research on short-term effects of air pollution on the health of airways of children with chronic respiratory complaints
Starting in 2017, researchers will commence their study on the effects of days with high air pollution on respiratory complaints, medication use and lung function of children suffering from chronic respiratory complaints such as wheezing or asthma. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 6, 2017 Category: Science Source Type: news

The burden of antimicrobial-resistant infections in black and minority ethnic groups
This Briefing Papercovers how overuse and misuse of antibiotics is one of the main drivers of antimicrobial resistance (AMR) – particularly prescribing antibiotics for upper respiratory tract infections (URTIs). It also examines how a history of recent travel (particularly to the Indian subcontinent) is correlated with a higher risk of colonisation with antibiotic-resistant bacteria. There is some evidence that ethnic v ariation in diet could influence the risk of developing an antimicrobial-resistant infection.Public knowledge of antimicrobial resistance and the behaviours contributing to it needs to reach all membe...
Source: Current Awareness Service for Health (CASH) - February 6, 2017 Category: Consumer Health News Source Type: news

Philips Wins Two Prestigious Awards for Sleep Therapy Manufacturer and Sleep Diagnostic Manufacturer of the Year 2017
Royal Philips (NYSE: PHG; AEX: PHIA) has won Sleep Therapy Manufacturer and Sleep Diagnostic Manufacturer of the Year at the Association for Respiratory Technology and Physiology (ARTP) Awards 2017. This is the first time for a company to win both awards. Philips is proud to have won the Sleep Therapy Manufacturer of the Year award previously in 2013, 2014 and 2015. (Source: eHealth News EU)
Source: eHealth News EU - February 6, 2017 Category: Information Technology Tags: Featured Philips Business and Industry Source Type: news

Medical News Today: Using NSAIDs during a cold may increase heart attack risk
Taking NSAIDs during acute respiratory infections such as a cold or flu may increase the risk of heart attack, new research finds. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 6, 2017 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

1 in 4 Teen E-Cigarette Users Has Tried 'Dripping'
Title: 1 in 4 Teen E-Cigarette Users Has Tried 'Dripping'Category: Health NewsCreated: 2/6/2017 12:00:00 AMLast Editorial Review: 2/6/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 6, 2017 Category: Respiratory Medicine Source Type: news

A bridge to breathing
(University of Pittsburgh) To safely bridge the time between diagnosis and transplant for pediatric patients with lung disease, a research team led by the University of Pittsburgh's Swanson School of Engineering is developing a compact respiratory assist device for children. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2017 Category: Global & Universal Source Type: news

Missing link for fighting viral pneumonia identified
According to the Centers for Disease Control, respiratory syncytial virus (RSV) causes about 60,000 hospitalizations of children aged 0 to four, and nearly 200,000 hospitalizations and 14,000 deaths among adults 65 and older. However, there are virtually no vaccines or treatments for these infections. In a new study, researchers found evidence that the cytokine, Interleukin 27 (IL-27), may be the key to fighting and treating these infections. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 4, 2017 Category: Science Source Type: news

Toxic particles from air pollution causing people's brains to swell... "city life" linked to brain deterioration
(Natural News) It’s no secret that air pollution is on the rise across the globe, especially in cities. In fact, a 2016 report from the World Health Organization indicated that outdoor pollution had risen by 8 percent in just five years. Beyond its environmental effects, air pollution is known for being harmful to the respiratory... (Source: NaturalNews.com)
Source: NaturalNews.com - February 4, 2017 Category: Consumer Health News Source Type: news

Acute pesticide ingestion managed with yohimbine as a rescue therapy - Nasa P, Juneja D.
Amitraz is used as a pesticide in agricultural and veterinary medicine. It is primarily a central α2 adrenergic agonist and known to cause central nervous system depression, convulsions, respiratory depression, and bradycardia on severe intoxication. We r... (Source: SafetyLit)
Source: SafetyLit - February 4, 2017 Category: Global & Universal Tags: Age: Infants and Children Source Type: news

Pulmatrix raises $3m in direct offering
Pulmatrix (NSDQ:PULM) said today that unnamed institutional investors agreed to purchase approximately $3.3 million of shares of common stock in a direct offering. The company said it plans to sell 950,000 shares at $3.50 apiece. Pulmatrix expects the offering, which will close next week, to bring in $3.0 million in proceeds to use for general corporate purposes and paying off some of its debt. The company saw its stock price soar in January after its drug candidate for treating fungal infections in the lungs of cystic fibrosis patients was designated as a ‘qualified infectious disease product’ by the FDA. Foll...
Source: Mass Device - February 3, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Drug-Device Combinations Funding Roundup Respiratory Wall Street Beat Pulmatrix Inc. Source Type: news

Monoclonal antibody given to preterm babies may reduce wheeze later
Preterm babies given the monoclonal antibody palivizumab to prevent respiratory syncytial virus (RSV) also appear less likely to develop recurrent wheeze, at least until the age of six, according to new research. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 3, 2017 Category: Science Source Type: news

Salicylic acid, a widespread ingredient in pain relief medications, promotes nasal mucosa colonization
An international research team has now shown that this multifaceted compound can also have an unpleasant side effect. Salicylic acid forms complexes with iron and lab tests showed that the iron limitation strongly promotes formation of biofilms by Staphylococcus aureus. This allows the bacteria to survive and persist in our respiratory tract for longer periods of time which eventually trigger life-threatening infections in immunocompromised persons. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 3, 2017 Category: Science Source Type: news

Adiposity Markers and Lung Function in Smokers Adiposity Markers and Lung Function in Smokers
This study examines the connection among smokers without respiratory disease.BMC Pulmonary Medicine (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 3, 2017 Category: Allergy & Immunology Tags: Pulmonary Medicine Journal Article Source Type: news

Salicylic acid promotes nasal mucosa colonization
(University of Veterinary Medicine -- Vienna) An international research team, including scientists from Vetmeduni Vienna, has now shown that this multifaceted compound can also have an unpleasant side effect. Salicylic acid forms complexes with iron and lab tests showed that the iron limitation strongly promotes formation of biofilms by Staphylococcus aureus. This allows the bacteria to survive and persist in our respiratory tract for longer periods of time which eventually trigger life-threatening infections in immunocompromised persons. Published in Frontiers in Microbiology. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 3, 2017 Category: Infectious Diseases Source Type: news

Monoclonal antibody given to preterm babies may reduce wheeze later
(American Thoracic Society) Preterm babies given the monoclonal antibody palivizumab to prevent respiratory syncytial virus (RSV) also appear less likely to develop recurrent wheeze, at least until the age of six, according to new research published online, ahead of print in the American Thoracic Society's American Journal of Respiratory and Critical Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 3, 2017 Category: Global & Universal Source Type: news

Flu shot may curb respiratory infections in people with heart failure
HealthDay News Flu and pneumonia vaccines may reduce heart failure patients' risk of dangerous respiratory infections, a new review suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 2, 2017 Category: Consumer Health News Source Type: news

Integration of FDA (Food and Drug Administration) and NIOSH (National Institute for Occupational Safety and Health) Processes Used to Evaluate Respiratory Protective Devices for Health Care Workers: Proceedings of a Workshop
National Academies Press. 01/2017 This 70-page document summarizes presentations and discussions from a workshop held in August 2016 that was focused on exploring the strengths and limitations of several current test methods for N95 respirators used by health care workers, as well as identifying ongoing research and research needs. The workshop was also organized to provide input to the National Institute for Occupational Safety and Health and and the Food and Drug Administration, and to discuss potential next steps to integrate the two agencies'processes to certify and approve N95 respirators for use in health care settin...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - February 2, 2017 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news

Sleepless Nights Linked to Asthma Later in Life
Adults with chronic insomnia 3 times more likely to develop the respiratory disorder, study suggests (Source: WebMD Health)
Source: WebMD Health - February 2, 2017 Category: Consumer Health News Source Type: news

Flu Shot May Curb Respiratory Infections in People with Heart Failure
Doctors should consider high-dose vaccine for those over 65, study suggests Source: HealthDay Related MedlinePlus Pages: Heart Failure, Immunization, Lung Diseases (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 2, 2017 Category: Consumer Health News Source Type: news

Pain meds used for colds, flu may raise heart attack risk
Amy WallaceFeb. 2 (UPI) -- Doctors at the National Taiwan University Hospital have found the use of pain relievers to treat respiratory infections may increase the risk of heart attack. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 2, 2017 Category: Consumer Health News Source Type: news

Advanced Inhalation Therapies raises $10m
Advanced Inhalation Therapies closed a $10.2 million offering yesterday. According to regulatory filings, 39 investors contributed to the offering, which made its 1st sale on Jan. 13. The Israel-based company is developing a drug delivery device to treat severe respiratory infections and lung diseases using a high dose of nitric oxide. The company plans to use $604,000 from the offering to compensate Ladenburg Thalmann & Co. Inc. for sales and $150,000 for executive officers, directors or promoters. Get the full story at our sister site, Drug Delivery Business News. The post Advanced Inhalation...
Source: Mass Device - February 2, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Drug-Device Combinations Funding Roundup Respiratory Advanced Inhalation Therapies Source Type: news

Common pain relievers may increase heart attack risk during respiratory infections
Widely used pain relievers may increase the risk of a heart attack when used during a cold or flu-like illness, according to a new study. The findings suggest physicians and patients should use caution when prescribing or taking the medications, known as nonsteroidal anti-inflammatory drugs, or NSAIDs, to ease symptoms of acute respiratory infections. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 2, 2017 Category: Science Source Type: news